rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1991-8-16
|
pubmed:abstractText |
Increased gamma-aminobutyric acid (GABA) neurotransmission has been implicated in the pathogenesis of hepatic encephalopathy. The mechanism by which GABA-ergic activity is increased in hepatic failure is unclear, but recent studies in animals with encephalopathy due to fulminant hepatic failure suggest that GABA-ergic neurotransmission may be increased by the presence of elevated concentrations of benzodiazepine agonists such as diazepam and N-desmethyldiazepam.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
325
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
473-8
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:1649403-Adult,
pubmed-meshheading:1649403-Aged,
pubmed-meshheading:1649403-Benzodiazepines,
pubmed-meshheading:1649403-Brain Chemistry,
pubmed-meshheading:1649403-Chromatography,
pubmed-meshheading:1649403-Diazepam,
pubmed-meshheading:1649403-Flumazenil,
pubmed-meshheading:1649403-Frontal Lobe,
pubmed-meshheading:1649403-Hepatic Encephalopathy,
pubmed-meshheading:1649403-Humans,
pubmed-meshheading:1649403-Mass Spectrometry,
pubmed-meshheading:1649403-Middle Aged,
pubmed-meshheading:1649403-Nordazepam,
pubmed-meshheading:1649403-Receptors, GABA-A,
pubmed-meshheading:1649403-Synaptic Transmission,
pubmed-meshheading:1649403-gamma-Aminobutyric Acid
|
pubmed:year |
1991
|
pubmed:articleTitle |
Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.
|
pubmed:affiliation |
Laboratory of Neuroscience, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
|
pubmed:publicationType |
Journal Article
|